How business strategy, healthcare innovation and long term vision transformed a family enterprise into a global group
The story of the Piramal business empire is one of transformation, strategic acquisitions and a commitment to innovation. At its centre are Ajay Piramal, who led the expansion of the family business into a diversified global group, and Dr. Swati Piramal, whose contributions to healthcare, pharmaceutical research and public health helped shape its growth.
From a Family Business to a Larger Vision
Ajay Piramal was born on August 3, 1955, into a business family with roots in the textile industry. The family enterprise had been established by his grandfather, and Ajay joined the business in 1977 after completing his education.
He graduated in science from the University of Mumbai and later earned a master’s degree in management studies from the Jamnalal Bajaj Institute of Management Studies. He also attended an Advanced Management Programme at Harvard Business School.
When Ajay took on a larger leadership role, he began looking beyond the traditional textile business. He recognised that the company’s future would depend on entering industries with stronger growth opportunities.
The Pharmaceutical Turning Point
One of the defining moments in Ajay Piramal’s business journey came in 1988, when the group acquired Nicholas Laboratories, an Australian pharmaceutical company with operations in India.
The acquisition marked a significant shift towards pharmaceuticals and healthcare. Under Ajay’s leadership, the business expanded its presence through acquisitions, research capabilities and the development of a broader pharmaceutical portfolio.
The group subsequently built a substantial presence in the Indian pharmaceutical market and developed international operations.
Another major milestone came in 2010, when Abbott acquired Piramal Healthcare’s domestic formulations business in a transaction valued at approximately $3.72 billion. The deal was among the most significant pharmaceutical transactions involving an Indian company at the time.
Rather than treating the transaction as an endpoint, the group used its evolving business portfolio to pursue new opportunities in pharmaceuticals, financial services and real estate.
Dr. Swati Piramal: Bringing Science into Business
While Ajay Piramal focused on business expansion and strategy, Dr. Swati Piramal brought a strong scientific and public-health perspective to the organisation.
A trained medical doctor, she earned her medical degree from the University of Mumbai and later completed a master’s degree in public health at Harvard.
Her work has focused on healthcare innovation, disease prevention, research and access to affordable healthcare. She has played an important role in developing the group’s pharmaceutical and healthcare capabilities.
Dr. Swati Piramal has also contributed to public-health initiatives and healthcare policy discussions. Her achievements were recognised with the Padma Shri in 2012 for her contribution to science and technology.
She serves as Vice Chairperson of the Piramal Group, bringing together scientific knowledge, business leadership and a commitment to social impact.
Expanding into Financial Services and Real Estate
Over the years, the Piramal Group diversified beyond pharmaceuticals. Financial services became an important part of its strategy, while real estate added another major business vertical.
The group pursued acquisitions, partnerships and investments to strengthen its position in these sectors. Its acquisition of Dewan Housing Finance Corporation through the insolvency resolution process in 2021 marked a significant development in its financial-services journey.
The business portfolio subsequently evolved into distinct operations, including Piramal Pharma, Piramal Finance and Piramal Realty.
This expansion reflects the group’s approach of entering businesses where it sees opportunities for long-term growth and institution-building.
Building a Global Business
Today, the Piramal Group has interests across pharmaceuticals, financial services and real estate, with operations and business relationships extending across international markets.
Ajay Piramal continues to serve as Chairman of the group, while Dr. Swati Piramal remains its Vice Chairperson. The next generation is also involved in leadership, with Nandini Piramal leading Piramal Pharma and Anand Piramal heading Piramal Finance.
The group’s evolution demonstrates how a family enterprise can adapt to changing markets through diversification, strategic investments and professional leadership.
A Commitment Beyond Business
The Piramal family’s vision also extends to social development. Through the Piramal Foundation, the group supports initiatives in healthcare, education, nutrition and community development.
Its work reflects the philosophy of “Doing Well and Doing Good”, the belief that business growth and social responsibility can progress together.
The journey of Ajay and Swati Piramal is therefore not simply about building a large business organisation. It is also about combining commercial ambition with scientific innovation and social purpose.
From a family textile business to a diversified group with international reach, their story illustrates the importance of adapting to change while building institutions for the future.
